Infant Mortality Reduction by the Mass Administration of Azithromycin
Status:
Not yet recruiting
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
This trial will investigate the supplementation of azithromycin distribution to the "Child
Health Days" platform in Burkina Faso for child mortality reduction. This distribution will
pair door-to-door administration of vitamin A and azithromycin or placebo with acute
malnutrition screening among children 1-11 months old.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Bill and Melinda Gates Foundation Centre de Recherche en Sante de Nouna, Burkina Faso Helen Keller International